King's College London

Research portal

Antiplatelet therapy in acute coronary syndrome

Research output: Contribution to journalArticle

Standard

Antiplatelet therapy in acute coronary syndrome. / Layne, Kerry; Ferro, Albert.

In: European Cardiology, Vol. 12, No. 1, 2017, p. 33-37.

Research output: Contribution to journalArticle

Harvard

Layne, K & Ferro, A 2017, 'Antiplatelet therapy in acute coronary syndrome', European Cardiology, vol. 12, no. 1, pp. 33-37. https://doi.org/10.15420/ecr.2016:34:2

APA

Layne, K., & Ferro, A. (2017). Antiplatelet therapy in acute coronary syndrome. European Cardiology, 12(1), 33-37. https://doi.org/10.15420/ecr.2016:34:2

Vancouver

Layne K, Ferro A. Antiplatelet therapy in acute coronary syndrome. European Cardiology. 2017;12(1):33-37. https://doi.org/10.15420/ecr.2016:34:2

Author

Layne, Kerry ; Ferro, Albert. / Antiplatelet therapy in acute coronary syndrome. In: European Cardiology. 2017 ; Vol. 12, No. 1. pp. 33-37.

Bibtex Download

@article{641eb05eded54792826640eda52e98a2,
title = "Antiplatelet therapy in acute coronary syndrome",
abstract = "Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects. The drug class continues to evolve as novel agents with increasingly efficacious antiplatelet actions are identified. This review will discuss antiplatelet agents, including aspirin, the P2Y12 receptor antagonists and the glycoprotein IIb/IIIa inhibitors, that are currently used to treat patients with unstable angina and myocardial infarction, focusing on their pharmacological properties and the clinical evidence supporting their use.",
keywords = "Acute coronary syndromes, Anti-inflammatory, Antiplatelet agent, Antithrombotic, Aspirin, Glycoprotein IIb/IIIa inhibitors, P2Y receptor antagonist",
author = "Kerry Layne and Albert Ferro",
year = "2017",
doi = "10.15420/ecr.2016:34:2",
language = "English",
volume = "12",
pages = "33--37",
journal = "European Cardiology",
issn = "1758-3756",
publisher = "Radcliffe Publishing Ltd.",
number = "1",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Antiplatelet therapy in acute coronary syndrome

AU - Layne, Kerry

AU - Ferro, Albert

PY - 2017

Y1 - 2017

N2 - Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects. The drug class continues to evolve as novel agents with increasingly efficacious antiplatelet actions are identified. This review will discuss antiplatelet agents, including aspirin, the P2Y12 receptor antagonists and the glycoprotein IIb/IIIa inhibitors, that are currently used to treat patients with unstable angina and myocardial infarction, focusing on their pharmacological properties and the clinical evidence supporting their use.

AB - Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects. The drug class continues to evolve as novel agents with increasingly efficacious antiplatelet actions are identified. This review will discuss antiplatelet agents, including aspirin, the P2Y12 receptor antagonists and the glycoprotein IIb/IIIa inhibitors, that are currently used to treat patients with unstable angina and myocardial infarction, focusing on their pharmacological properties and the clinical evidence supporting their use.

KW - Acute coronary syndromes

KW - Anti-inflammatory

KW - Antiplatelet agent

KW - Antithrombotic

KW - Aspirin

KW - Glycoprotein IIb/IIIa inhibitors

KW - P2Y receptor antagonist

UR - http://www.scopus.com/inward/record.url?scp=85027398942&partnerID=8YFLogxK

U2 - 10.15420/ecr.2016:34:2

DO - 10.15420/ecr.2016:34:2

M3 - Article

AN - SCOPUS:85027398942

VL - 12

SP - 33

EP - 37

JO - European Cardiology

JF - European Cardiology

SN - 1758-3756

IS - 1

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454